Status:
RECRUITING
Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients
Lead Sponsor:
Uşak University
Conditions:
Diabetic Group (n=30)
Non-diabetic Group
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
By comparing DEL-1 and IL-17 levels in the aqueous humor of diabetic cataract patients with the aqueous humor of non-diabetic patients, we aim to understand the biochemical effects of diabetes-related...
Detailed Description
Developmental Endothelial Locus-1 (DEL-1) is a molecule related to endothelial cells and is a protein involved in intercellular interactions. It is generally associated with the development and functi...
Eligibility Criteria
Inclusion
- Cataract diagnosed and surgery planned
- Patients without any other ocular pathology other than cataract.
- Type 2 DM for at least 5 years in the diabetic group
Exclusion
- Patients with previous intraocular surgery
- Those with inflammatory eye diseases (e.g. uveitis)
- Those with autoimmune diseases or systemic inflammatory diseases
- Those receiving local or systemic steroid therapy
- Those with severe systemic disease (e.g. advanced renal failure, malignancy)
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06995131
Start Date
May 1 2025
End Date
August 15 2025
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uşak Training and Research Hospital
Uşak, Uşak, Turkey (Türkiye), 64000